Comparative Study
doi: 10.1016/0264-410x(91)90266-9.
Antibody assays suitable for assessing immune responses to live varicella vaccine
Affiliations
- PMID: 1647574
- DOI: 10.1016/0264-410x(91)90266-9
Item in Clipboard
Comparative Study
Antibody assays suitable for assessing immune responses to live varicella vaccine
Vaccine.
1991 Feb.
Abstract
An enzyme-linked immunosorbent assay for antibodies to varicella-zoster virus (VZV), using purified viral glycoproteins as antigen (gpELISA), was compared with other assays for measuring vaccine-induced antibody responses. The gpELISA was more sensitive than conventional assays, proved highly specific for VZV and agreed well with an assay for neutralizing antibody activity. It was successfully applied to large-scale testing of live varicella vaccine in humans.
Similar articles
-
Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.J Clin Microbiol. 2006 Sep;44(9):3094-7. doi: 10.1128/JCM.00719-06. J Clin Microbiol. 2006. PMID: 16954232 Free PMC article.
-
Antibodies to varicella-zoster virus glycoproteins I, II, and III in leukemic and healthy children.J Infect Dis. 1990 Sep;162(3):627-33. doi: 10.1093/infdis/162.1.627. J Infect Dis. 1990. PMID: 2167335
-
Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.J Infect Dis. 1988 Dec;158(6):1245-52. doi: 10.1093/infdis/158.6.1245. J Infect Dis. 1988. PMID: 2848901
-
Assays for antibodies to varicella-zoster virus.Infect Dis Clin North Am. 1996 Sep;10(3):507-27. doi: 10.1016/s0891-5520(05)70311-1. Infect Dis Clin North Am. 1996. PMID: 8856350 Review.
-
Cell-mediated immunity to varicella-zoster virus.J Infect Dis. 1992 Aug;166 Suppl 1:S35-41. doi: 10.1093/infdis/166.supplement_1.s35. J Infect Dis. 1992. PMID: 1320649 Review.
Cited by
-
Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay.Clin Vaccine Immunol. 2006 Feb;13(2):214-8. doi: 10.1128/CVI.13.2.214-218.2006. Clin Vaccine Immunol. 2006. PMID: 16467328 Free PMC article.
-
Incidence of varicella in children in Jeju-do, Korea, 2005-2016: age-period-cohort analysis.Epidemiol Health. 2018;40:e2018054. doi: 10.4178/epih.e2018054. Epub 2018 Nov 8. Epidemiol Health. 2018. PMID: 30428643 Free PMC article.
-
Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent Assay.Sci Rep. 2016 Feb 8;6:20577. doi: 10.1038/srep20577. Sci Rep. 2016. PMID: 26853741 Free PMC article.
-
Vaccination to prevent varicella and shingles.J Clin Pathol. 2001 Oct;54(10):743-7. doi: 10.1136/jcp.54.10.743. J Clin Pathol. 2001. PMID: 11577118 Free PMC article.
-
A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II).Hum Vaccin Immunother. 2020 Nov 1;16(11):2634-2640. doi: 10.1080/21645515.2020.1743122. Epub 2020 May 19. Hum Vaccin Immunother. 2020. PMID: 32429738 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
